ArticleBreast cancer (Dove Medical Press)2021

Cost-effectiveness of Tamoxifen, Aromatase Inhibitor, and Switch Therapy (Adjuvant Endocrine Therapy) for Breast Cancer in Hormone Receptor Positive Postmenopausal Women in India.

Dimple Butani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.